ABT vs BMY
Abbott Laboratories vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | ABT | BMY |
|---|---|---|
| AI Score | 55 | 55 |
| Price | $100.58 | $60.77 |
| P/E Ratio | 27.69× | 17.12× |
| ROE | 0.1% | 0.4% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.6% | 0.7% |
| Debt / Equity | 0.65× | 2.22× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 64.7 | 65.0 |
| Beta | 0.607 | 0.235 |
| Expected Upside | +6.9% | +0.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ABT Full Analysis
BMY Full Analysis